{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:21:53Z","timestamp":1792840913474,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1940-0640-7-19","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T10:14:07Z","timestamp":1348481647000},"source":"Crossref","is-referenced-by-count":51,"title":["Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: An extensive case with necrosis of skin, soft tissue, and cartilage"],"prefix":"10.1186","volume":"7","author":[{"given":"Natasha Purai","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Bhanot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganthini Krishnan","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,24]]},"reference":[{"issue":"16","key":"114_CR1","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2011.531","volume":"305","author":"JA Buchanan","year":"2011","unstructured":"Buchanan JA, Heard K, Burbach C, Wilson ML, Dart R: Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA. 2011, 305 (16): 1657-1658. 10.1001\/jama.2011.531.","journal-title":"JAMA"},{"key":"114_CR2","first-page":"1381","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC): Agranulocytosis associated with cocaine use\u2014four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep. 2009, 58: 1381-1385.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"114_CR3","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10067-011-1805-3","volume":"30","author":"RL Gross","year":"2011","unstructured":"Gross RL, Brucker J, Bahce-Altuntas A, Abadi MA, Lipoff J, Kotlyar D, Barland P, Putterman C: A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol. 2011, 30 (10): 1385-1392. 10.1007\/s10067-011-1805-3.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"114_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","volume":"17","author":"K Ullrich","year":"2011","unstructured":"Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM: Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol. 2011, 17 (4): 193-196.","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"114_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0192-0561(92)90179-O","volume":"14","author":"WK Amery","year":"1992","unstructured":"Amery WK, Bruynseels JP: Levamisole, the story and the lessons. Int J Immunopharmacol. 1992, 14 (3): 481-486. 10.1016\/0192-0561(92)90179-O.","journal-title":"Int J Immunopharmacol"},{"issue":"6110","key":"114_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/bmj.1.6110.407","volume":"1","author":"DG Macfarlane","year":"1978","unstructured":"Macfarlane DG, Bacon PA: Levamisole-induced vasculitis due to circulating immune complexes. Br Med J. 1978, 1 (6110): 407-408. 10.1136\/bmj.1.6110.407.","journal-title":"Br Med J"},{"issue":"11","key":"114_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-152-11-201006010-00026","volume":"152","author":"M Bradford","year":"2010","unstructured":"Bradford M, Rosenberg B, Moreno J, Dumyati G: Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med. 2010, 152 (11): 758-759.","journal-title":"Ann Intern Med"},{"issue":"1","key":"114_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13181-010-0097-3","volume":"7","author":"JA Buchanan","year":"2011","unstructured":"Buchanan JA, Vogel JA, Eberhardt AM: Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol. 2011, 7 (1): 83-84. 10.1007\/s13181-010-0097-3.","journal-title":"J Med Toxicol"},{"issue":"12","key":"114_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1600-0560.2010.01613.x","volume":"37","author":"NMG Walsh","year":"2010","unstructured":"Walsh NMG, Green PJ, Burlingame RW, Pasternak S, Hanly JG: Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol. 2010, 37 (12): 1212-1219. 10.1111\/j.1600-0560.2010.01613.x.","journal-title":"J Cutan Pathol"},{"issue":"3","key":"114_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jaad.2010.01.055","volume":"63","author":"JM Waller","year":"2010","unstructured":"Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP: Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?. J Am Acad Dermatol. 2010, 63 (3): 530-535. 10.1016\/j.jaad.2010.01.055.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"114_CR11","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/archdermatol.2010.335","volume":"146","author":"EK Farhat","year":"2010","unstructured":"Farhat EK, Moorhead TT, Chaffing ML, Douglass MC: Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol. 2010, 146 (11): 1320-1321. 10.1001\/archdermatol.2010.335.","journal-title":"Arch Dermatol"},{"issue":"2","key":"114_CR12","first-page":"217","volume":"10","author":"J Click","year":"2011","unstructured":"Click J: Levamisole-induced retiform purpura. J Drug Dermatol. 2011, 10 (2): 217-","journal-title":"J Drug Dermatol"},{"issue":"2","key":"114_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D33Q1500T8","volume":"17","author":"L Geller","year":"2011","unstructured":"Geller L, Whang TB, Mercer SE, Phelps R: Retiform purpura: a new stigmata of illicit drug use?. Dermatol Online J. 2011, 17 (2): 7.","journal-title":"Dermatol Online J"},{"issue":"9","key":"114_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1503\/cmaj.101005","volume":"183","author":"C Han","year":"2011","unstructured":"Han C, Sreenivasan G, Dutz JP: Reversible retiform purpura: a sign of cocaine use. CMAJ. 2011, 183 (9): 597-600. 10.1503\/cmaj.101005.","journal-title":"CMAJ"},{"issue":"1","key":"114_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BCR.0b013e318233fc64","volume":"33","author":"JA Ching","year":"2012","unstructured":"Ching JA, Smith DJ: Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res. 2012, 33 (1): 1-5. 10.1097\/BCR.0b013e31823347f6.","journal-title":"J Burn Care Res"},{"issue":"10","key":"114_CR16","first-page":"1204","volume":"10","author":"J Mouzakis","year":"2011","unstructured":"Mouzakis J, Somboonwit C, Lakshmi S, Rumbak M, Sinnott J, Cherpelis B, Keshishian J: Levamisole-induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome. J Drugs Dermatol. 2011, 10 (10): 1204-1207.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"114_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/DAD.0b013e31821cc0bf","volume":"34","author":"RS Jacob","year":"2012","unstructured":"Jacob RS, Silva CY, Powers JG, Schieke SM, Mendese G, Burlingame RW, Miller DD, Wolpowitz D, Graber E, Mahalingam M: Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012, 34 (2): 208-213. 10.1097\/DAD.0b013e31821cc0bf.","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"114_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.annemergmed.2010.05.009","volume":"57","author":"D Lung","year":"2011","unstructured":"Lung D, Lynch K, Agrawal S, Armenian P, Banh K: Images in emergency medicine, adult female with rash on lower extremities. vasculopathic purpura and neutropenia caused by levamisole-contaminated cocaine. Ann Emerg Med. 2011, 57 (3): 307-311. 10.1016\/j.annemergmed.2010.05.009.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"114_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/RHU.0b013e31821cb9d5","volume":"17","author":"NA Zwang","year":"2011","unstructured":"Zwang NA, Van Wagner LB, Rose S: A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol. 2011, 17 (4): 197-200.","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"114_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2010.08.024","volume":"65","author":"C Chung","year":"2011","unstructured":"Chung C, Tumeh PC, Birnbaum R, Tan BH, Sharp L, McCoy E, Mercurio MG, Craft N: Characteristic purpura of the ears, vasculitis, and neutropenia\u2013a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol. 2011, 65 (4): 722-725. 10.1016\/j.jaad.2010.08.024.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"114_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jaad.2010.09.778","volume":"65","author":"J Jenkins","year":"2011","unstructured":"Jenkins J, Babu K, Hsu-Hung E, Robinson-Bostom L, Kroumpouzos G: ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation. J Am Acad Dermatol. 2011, 65 (1): 14-16.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"114_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/MAJ.0b013e31822979f1","volume":"342","author":"S John","year":"2011","unstructured":"John S, Manda S, Hamrock D: Cocaine-induced thrombotic vasculopathy. Am J Med Sci. 2011, 342 (6): 524-526. 10.1097\/MAJ.0b013e31822979f1.","journal-title":"Am J Med Sci"},{"issue":"8022","key":"114_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(77)92386-8","volume":"1","author":"DR Parkinson","year":"1977","unstructured":"Parkinson DR, Cano PO, Jerry LM, Capek A, Shibata HR, Mansell PW, Lewis MG, Marquis G: Complications of cancer immunotherapy with levamisole. Lancet. 1977, 1 (8022): 1129-1132.","journal-title":"Lancet"},{"issue":"6086","key":"114_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/bmj.2.6086.555","volume":"2","author":"AW Segal","year":"1977","unstructured":"Segal AW, Pugh SF, Levi AJ, Loewi G: Levamisole-induced arthritis in Crohn\u2019s disease. Br Med J. 1977, 2 (6086): 555.","journal-title":"Br Med J"},{"issue":"4","key":"114_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/adc.75.4.355-b","volume":"75","author":"R Laux-End","year":"1996","unstructured":"Laux-End R, Inabenit D, Gerber HA, Bianchetti MG: Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child. 1996, 75 (4): 355-356.","journal-title":"Arch Dis Child"},{"issue":"3","key":"114_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/clpt.2010.156","volume":"88","author":"A Chang","year":"2010","unstructured":"Chang A, Osterloh J, Thomas J: Levamisole: a dangerous new adulterant. Clin Pharmacol Ther. 2010, 88 (3): 408-411. 10.1038\/clpt.2010.156.","journal-title":"Clin Pharmacol Ther"},{"issue":"23","key":"114_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/vr.122.23.558","volume":"122","author":"Q McKellar","year":"1988","unstructured":"McKellar Q, Marriner S, Bogan J: Comparison of ivermectin, oxfendazole and levamisole for use as anthelmintics during the periparturient period in sheep. Vet Rec. 1988, 122 (23): 558-560. 10.1136\/vr.122.23.558.","journal-title":"Vet Rec"},{"issue":"8","key":"114_CR28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2460\/ajvr.1986.47.08.1677","volume":"47","author":"FG Hembry","year":"1986","unstructured":"Hembry FG, Miller JE, Sims D, Rodriguez S, Stagg LC: Efficacy of repeated doses of levamisole, morantel, fenbendazole, and ivermectin against gastrointestinal nematodes in ewes. Am J Vet Res. 1986, 47 (8): 1677-1679.","journal-title":"Am J Vet Res"},{"issue":"3,4","key":"114_CR29","first-page":"82","volume":"6","author":"JF Casale","year":"2008","unstructured":"Casale JF, Corbeil EM, Hays PA: Identification of levamisole impurities found in illicit cocaine exhibits. Microgram J. 2008, 6 (3,4): 82-89.","journal-title":"Microgram J"},{"issue":"1","key":"114_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS: Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001, 39 (1): 32-41. 10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.","journal-title":"Synapse"},{"issue":"1","key":"114_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","volume":"75","author":"LL Howell","year":"2008","unstructured":"Howell LL, Kimmel HL: Monoamine transporters and psychostimulant addiction. Biochem Pharmacol. 2008, 75 (1): 196-217. 10.1016\/j.bcp.2007.08.003.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"114_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1090-0233(05)80005-X","volume":"154","author":"RJ Martin","year":"1997","unstructured":"Martin RJ: Modes of action of anthelmintic drugs. Vet J. 1997, 154 (1): 11-34. 10.1016\/S1090-0233(05)80005-X.","journal-title":"Vet J"},{"issue":"9","key":"114_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jat\/33.9.620","volume":"33","author":"LP Raymon","year":"2009","unstructured":"Raymon LP, Isenschmid DS: Letter to the editor: the possible role of levamisole in illicit cocaine preparations. J Anal Toxicol. 2009, 33 (9): 620-622.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"114_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.aca.2009.02.033","volume":"638","author":"EN Ho","year":"2009","unstructured":"Ho EN, Leung DK, Leung GN, Wan TS, Wong AS, Wong CH, Soma LR, Rudy JA, Uboh C, Sams R: Aminorex and rexamino as metabolites of levamisole in the horse. Anal Chim Acta. 2009, 638 (1): 58-68. 10.1016\/j.aca.2009.02.033.","journal-title":"Anal Chim Acta"},{"issue":"11","key":"114_CR35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0196-0644(88)80078-7","volume":"17","author":"M Shannon","year":"1988","unstructured":"Shannon M: Clinical toxicity of cocaine adulterants. Ann Emerg Med. 1988, 17 (11): 1243-1247. 10.1016\/S0196-0644(88)80078-7.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"114_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4065\/80.5.671","volume":"80","author":"DR Friedman","year":"2005","unstructured":"Friedman DR, Wolfsthal SD: Cocaine-induced pseudovasculitis. Mayo Clin Proc. 2005, 80 (5): 671-673. 10.4065\/80.5.671.","journal-title":"Mayo Clin Proc"},{"key":"114_CR37","volume-title":"The","author":"Office of Applied Studies (OAS), Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2005","unstructured":"Office of Applied Studies (OAS), Substance Abuse and Mental Health Services Administration (SAMHSA): The. 2005, http:\/\/www.oas.samhsa.gov\/2k5\/cocaine\/cocaine.pdf , National Survey on Drug Use and Health Report,"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1940-0640-7-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1940-0640-7-19\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1940-0640-7-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:07:47Z","timestamp":1744175267000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/1940-0640-7-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1186\/1940-0640-7-19","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,24]]},"article-number":"19"}}